Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
---|---|---|---|---|
Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
Börsenplätze | Performance | Management | Volatilität | Watchlist |
Historisch | Benchmark | Dokumente | Sharpe Ratio | |
Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Anlageziel Amundi Funds - Emerging Markets Equity ESG Improvers R2 USD (C) Fonds
The Sub-Fund Seeks to increase the value of your investment over the recommended holding period. The Sub-Fund invests mainly in a broad range of equities and equity-linked instruments of companies from anywhere in emerging countries. Investments in Chinese equities can be made either through authorised markets in Hong Kong, via the Stock Connect or the QFI licence system. The Sub-Fund’s total investment exposure to China A shares and B Shares (combined) will be less than 30% of net assets. The Sub-Fund may also invest up to 10% of its assets in P-Notes for the purpose of efficient portfolio management.
Stammdaten
Valor | |
ISIN | LU2386147081 |
Fondsgesellschaft | Amundi |
Kategorie | Aktien Schwellenländer |
Währung | USD |
Mindestanlage | - |
VL-fähig? | Nein |
Thesaurierend/Ausschüttend | Thesaurierend |
Fondsmanager |
Aktuelle Daten
Fondsnote | - |
Aktueller Rücknahmepreis | 53.24 |
Fonds Volumen | 190’318’115.49USD |
Total Expense Ratio (TER) | 1.33% |
Gebühren
Verwaltungsgebühr | - |
Depotbankgebühr | - |
Rücknahmegebühr | - |
Ausgabeaufschlag | 0.00 % |
Basisdaten
Auflagedatum | 10.03.2022 |
Depotbank | CACEIS Bank, Luxembourg Branch |
Zahlstelle | CACEIS Bank, Paris, Nyon branch |
Domizil | Luxembourg |
Geschäftsjahr | 30.06.2024 |
Performancedaten
Veränderung Vortag | 0.59 USD (1.12 %) |